S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Merck and Isomorphic Labs Team Up on Cancer Drug Research

Merck and AI drug-design company Isomorphic Labs will search for small-molecule drug candidates against an oncology target the companies describe as strategically important. Under the collaboration, Isomorphic will generate molecular designs, while Merck supplies the data and leads development if a product emerges.

Merck and Isomorphic Labs Team Up on Cancer Drug Research

Merck will provide datasets for Isomorphic Labs’ artificial-intelligence-enabled drug-design engine. Isomorphic will deliver molecular designs produced by the system, according to the companies’ announcement on Thursday.

Merck will take responsibility for preclinical and clinical development, manufacturing and commercialization of any products arising from the work. “By combining Merck's substantial internal data capabilities and discovery expertise with Isomorphic Labs' powerful modeling and compute capabilities, we aim to identify new ways to design and create better candidates faster,” said George Addona, head of discovery for preclinical development and translational medicine at Merck Research Laboratories.

The financial terms include an undisclosed upfront payment from Merck to Isomorphic Labs. Isomorphic is also eligible for payments tied to specified research, development, regulatory and commercial milestones, plus tiered royalties on net sales. The agreement gives Isomorphic an option to co-fund development activities in exchange for elevated royalties.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!